The increased motility of CRC cells suggested visfatin may modulate the EMT process, of which the epithelial makers E-cad is down-regulated, whereas the mesenchymal markers N-cad and Vim are up-regulated [20]. The gene discussed is VIM; the disease is colorectal carcinoma.